WallStreetZenWallStreetZen

NASDAQ: TXMD
Therapeuticsmd Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their TXMD stock forecasts and price targets.

Forecast return on equity

Is TXMD forecast to generate an efficient return?

Company
15.14%
Industry
27.57%
Market
298.04%
TXMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TXMD forecast to generate an efficient return on assets?

Company
10.73%
Industry
12.17%
TXMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TXMD earnings per share forecast

What is TXMD's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.36

TXMD revenue forecast

What is TXMD's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$9.3M+262.72%

TXMD vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TXMD$1.25N/AN/A
GELS$1.22N/AN/A
BFRI$1.06$2.75+159.43%Strong Buy
SXTC$1.32N/AN/A
YCBD$1.03$2.00+94.17%Strong Buy
View Top Pharmaceutical Stocks

Therapeuticsmd Stock Forecast FAQ

What is TXMD's earnings growth forecast for 2025-2025?

(NASDAQ: TXMD) Therapeuticsmd's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Therapeuticsmd's earnings in 2025 is -$459,000.

In 2025, TXMD is forecast to generate $4,132,047 in earnings, with the lowest earnings forecast at $3,970,006 and the highest earnings forecast at $4,253,578.

If you're new to stock investing, here's how to buy Therapeuticsmd stock.

What is TXMD's revenue growth forecast for 2025-2025?

(NASDAQ: TXMD) Therapeuticsmd's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Therapeuticsmd's revenue in 2025 is $2,559,000.

In 2025, TXMD is forecast to generate $107,433,228 in revenue, with the lowest revenue forecast at $103,220,160 and the highest revenue forecast at $110,593,029.

What is TXMD's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: TXMD) forecast ROA is 10.73%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 12.17%.

What is TXMD's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: TXMD) Therapeuticsmd's current Earnings Per Share (EPS) is -$0.04. In 2025, TXMD's EPS is forecast to hit $0.36 (min: $0.34, max: $0.37).

What is TXMD's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: TXMD) forecast ROE is 15.14%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.